Benign neoplasm: Ribs, sternum and clavicle

CD2_BENIGN_RIBS_STERNUM_CLAVICLE_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D16.7& Hospital discharge: ICD-9 — 2133 Hospital discharge: ICD-8 — 21302 Cause of death: ICD-10 — D16.7& Cause of death: ICD-9 — 2133 Cause of death: ICD-8 — 21302 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D16
Name in latin: Neoplasma benignum costae, sterni sive claviculae

NAME	CD2_BENIGN_RIBS_STERNUM_CLAVICLE_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D167
HD_ICD_9	2133
HD_ICD_8	21302
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D167
COD_ICD_9	2133
COD_ICD_8	21302
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Ribs, sternum and clavicle based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Ribs, sternum and clavicle

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	82	42	40
Unadjusted period prevalence (%)	0.02	0.01	0.02
Median age at first event (years)	41.50	45.12	37.70

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
79: Matched controls
790

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D16.7

ICD-10 Finland

Benign neoplasm: Ribs, sternum and clavicle

+∞

51.9

21302

ICD-8 Finland

Benign neoplasm of bone and cartilage, Costae, sterni, claviculae

+∞

26.5

2133A

ICD-9 Finland

Benign neoplasm of bone and articular cartilage, Ribs, sternum and clavicle

+∞

11.7

GAE06

NOMESCO Finland

Excision of lesion of chest wall

+∞

7.4

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

29.3

6.4

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

8.0

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3042936) Bacteria identified in Isolate by Culture

2.49

2.52

1.1

2.8

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

365

1.95

2.21

8.4

6.3

3.5

4.2

e9/l

1.64

317

(40768804) Tissue Pathology biopsy report

194

1.96

2.14

2.1

1.5

—

(4010399)

2.67

2.03

1.5

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

119

2.03

1.89

2.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3.72

1.87

1.5

1.9

16.5

19.9

u/ml

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

120

2.01

1.85

1.3

22.2

10.6

u/ml

—

(3026493) Urate [Moles/volume] in Serum or Plasma

169

1.89

1.83

1.8

2.3

294.8

2613.8

umol/l

0.51

143

(3044640) Blood type and Crossmatch panel - Blood

170

1.88

1.80

2.3

2.2

—

(40768443) Skin Pathology biopsy report

3.51

1.78

1.2

—

(3032080) INR in Blood by Coagulation assay

240

1.80

1.77

4.5

8.3

1.1

1.3

inr

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

250

1.78

1.74

3.4

4.3

—

(3026008) Bacteria identified in Urine by Culture

181

1.83

1.71

2.5

2.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.17

1.66

1.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3.73

1.64

2.4

1.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

126

1.90

1.60

1.4

1.3

9.1

40.4

iu/ml

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

3.00

1.53

1.7

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2.86

1.46

1.7

1.2

—

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2.86

1.46

1.7

1.2

—

3.7

—

(3002256) Pathology report gross observation

2.40

1.45

1.0

1.1

—

(42870588) Differential panel, method unspecified - Blood

219

1.67

1.35

8.2

5.1

—

(4035726)

2.89

1.30

1.8

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1.89

1.25

4.6

4.3

36.2

32.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2.73

1.23

1.8

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

121

1.74

1.19

1.2

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

157

1.65

1.12

1.2

1.3

0.9

1.2

u/ml

—

(3000991) Gas panel - Venous blood

2.12

1.09

4.1

10.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.84

1.06

2.5

2.8

2.4

g/l

2.29

(3024561) Albumin [Mass/volume] in Serum or Plasma

261

1.52

1.00

3.3

3.8

35.8

36.3

g/l

0.24

244

(3013826) Glucose [Moles/volume] in Serum or Plasma

387

1.50

0.99

3.2

5.0

6.6

mmol/l

0.02

357

(3031040) Bacteria [#/volume] in Urine by Automated count

402

1.47

0.90

5.5

3.9

—

39.4

—

(36660697) Celiac disease serology panel - Serum

1.80

0.87

1.1

—

(3025941) Bacteria identified in Stool by Culture

1.94

0.83

1.7

1.4

—

(3019225) pH of Specimen

1.77

0.83

3.8

2.9

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1.78

0.83

2.4

3.2

124.3

124.0

ng/l

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

214

1.47

0.82

4.1

2.9

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.88

0.81

5.7

11.2

0.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

520

1.48

0.81

4.4

4.0

15.1

14.7

pmol/l

0.66

471

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.78

0.79

1.6

1.7

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.82

0.78

5.7

11.0

2.2

2.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.75

0.78

1.6

1.8

—

(3044889) 12 lead EKG panel

460

0.71

0.76

4.9

3.8

—

(1761868) Lipid panel - Serum or Plasma

254

0.67

0.74

2.4

3.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.84

0.67

1.6

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.84

0.67

1.8

3.9

—

(3020891) Body temperature

1.84

0.67

2.2

2.8

—

(40768797) Stomach Pathology biopsy report

1.55

0.67

1.6

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.63

0.66

12.3

6.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.70

0.64

1.0

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

521

1.39

0.62

5.6

3.9

11.3

11.4

mm/h

0.00

471

(3007853) Bacteria identified in Skin by Aerobe culture

1.51

0.55

1.2

1.7

—

(3022145) Colonoscopy Study observation

1.49

0.48

1.5

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.50

0.48

1.1

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1.47

0.47

1.3

2.1

0.2

g/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

671

1.43

0.45

15.6

11.7

20.2

19.9

mg/l

0.02

495

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

632

0.76

0.44

6.3

6.2

40.1

40.3

mmol/mol

0.08

589

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.42

0.43

1.3

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.42

0.43

1.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.39

0.42

3.4

3.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

0.00

0.41

0.0

3.7

—

38.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.46

0.40

2.2

1.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

435

1.25

0.39

5.0

4.0

—

(36304419) Bacteria [Presence] in Urine

163

1.30

0.39

4.3

2.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

118

1.33

0.37

3.1

2.6

0.5

0.8

ug/l

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

623

1.30

0.36

5.5

4.8

2.0

1.9

mu/l

0.39

566

(40761536) Microorganisms panel - Urine sediment

1.36

0.34

3.2

4.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

214

1.24

0.33

3.0

3.8

1.5

8.6

mg/mmol

2.31

139

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

167

1.26

0.32

3.2

3.7

18.6

24.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

102

1.33

0.32

3.9

2.4

9.2

0.7

e6/l

—

(3023368) Bacteria identified in Blood by Culture

139

1.28

0.32

3.6

4.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

254

1.22

0.31

2.3

2.1

101.8

99.6

pmol/l

0.10

127

(3013512) EKG study

208

1.22

0.28

3.0

4.1

—

(3012516) Albumin [Mass/volume] in Urine

199

1.22

0.27

2.7

3.1

11.6

57.5

mg/l

2.06

130

(3011397) Hemoglobin [Presence] in Urine by Test strip

143

1.24

0.26

4.4

3.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

239

1.19

0.25

3.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

153

1.23

0.25

4.6

4.5

—

(3015736) pH of Urine

240

1.19

0.24

3.9

3.3

—

(3030467) Casts [#/volume] in Urine by Automated count

173

1.21

0.24

4.3

2.9

0.4

0.2

e6/l

0.29

125

(3019060) Gas panel - Arterial blood

1.30

0.23

2.4

14.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

145

1.22

0.23

1.2

1.3

3.1

2.6

g/l

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.27

0.22

3.0

2.4

12.2

13.5

umol/l

0.32

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.20

0.22

2.0

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

0.21

0.0

1.5

—

90.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

0.00

0.21

0.0

1.1

—

9.6

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.21

0.0

2.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

(40761535) Cells panel - Urine sediment

1.30

0.21

4.0

2.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.21

0.0

1.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

0.00

0.21

0.0

2.2

—

3.4

—

(3014051) Protein [Presence] in Urine by Test strip

0.00

0.20

0.0

1.3

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.20

0.0

3.1

—

106.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.20

0.0

3.1

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.20

0.0

3.1

—

4.1

—

(3021589) Normoblasts [#/volume] in Blood

286

0.87

0.19

10.2

8.4

0.0

e9/l

0.00

230

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

101

1.22

0.18

4.3

2.6

4.5

2.8

e6/l

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

640

0.87

0.15

3.8

4.3

1.3

mmol/l

0.09

589

(3041096) Erythrocytes [Presence] in Urine by Automated

177

0.88

0.11

3.1

3.7

—

(3002582) Erythrocytes [#/volume] in Urine

194

1.11

0.10

4.3

2.9

758.5

365.9

e6/l

0.20

147

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.17

0.10

1.4

1.5

—

(3003694) ABO and Rh group [Type] in Blood

143

0.89

0.08

1.5

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

465

0.93

0.08

3.4

3.0

50.3

41.1

u/l

0.55

442

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

660

1.08

0.04

4.0

4.7

4.8

4.7

mmol/l

0.68

616

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.11

0.04

3.6

3.0

0.9

0.8

mmol/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

421

0.95

0.04

2.7

2.9

—

(3009261) Glucose [Presence] in Urine by Test strip

322

1.04

0.02

3.9

3.6

0.0

estimate

—

(3019150) Specific gravity of Urine by Refractometry

143

1.06

0.01

4.3

3.7

—

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

653

1.05

0.01

5.2

4.5

6.0

mmol/l

0.01

598

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

607

0.96

0.01

15.4

11.4

82.5

79.8

ml/min/173m2

0.50

486

(3035350) Ketones [Presence] in Urine by Test strip

313

1.04

0.01

4.0

3.6

0.0

estimate

—

(40761511) CBC panel - Blood by Automated count

694

1.06

0.01

16.7

10.6

—

(40758558) Short blood count panel - Blood

153

0.98

0.00

5.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

283

0.98

0.00

3.7

3.6

18.6

56.0

ng/l

1.74

187

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

655

1.04

0.00

4.1

4.7

1.6

1.5

mmol/l

0.84

607

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

674

0.97

0.00

4.5

5.2

2.9

2.8

mmol/l

0.37

623

(3018095) Leukocytes [#/volume] in Urine

224

0.98

0.00

5.4

3.3

99.8

118.1

e6/l

0.09

151

(3009542) Hematocrit [Volume Fraction] of Blood

606

1.03

0.00

18.0

13.5

40.9

40.5

0.20

436

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.98

0.00

1.7

1.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

0.97

0.00

1.9

5.0

1.1

1.0

mmol/l

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

0.96

0.00

1.0

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

0.0

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.0

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.0

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.02

0.00

1.0

2.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.0

1.4

—

33.8

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

0.0

3.0

—

2.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.0

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

1.2

—

(4027681)

0.00

0.0

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

0.98

0.00

1.3

1.5

—

(3012565) Volume of 24 hour Urine

0.00

0.0

1.2

—

1965.8

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.3

—

105.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.93

0.00

1.0

1.6

—

(3011648) Oxygen content in Venous blood

0.00

0.0

2.3

—

11.9

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

0.00

0.0

1.4

—

138.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.0

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.9

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.0

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3026470) Cobalt [Mass/volume] in Blood

0.00

0.0

1.6

—

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.0

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3006245) CD3-CD19+ cells/100 cells in Blood

0.00

0.0

2.8

—

11.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.92

0.00

1.0

2.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.0

—

(44806420)

0.00

0.0

2.8

—

(3000494) Fungus identified in Specimen by Culture

0.88

0.00

1.3

1.7

—

(3012544) pH of Venous blood

1.00

0.00

1.6

4.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.0

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

2.8

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.0

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.0

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

0.95

0.00

1.2

1.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.0

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.4

—

(4198724)

0.00

0.0

1.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

0.98

0.00

5.8

1.8

8.8

10.9

g/l

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

0.00

0.0

2.8

—

26.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

279.4

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

0.0

2.4

—

115.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_RIBS_STERNUM_CLAVICLE_EXALLC – Benign neoplasm: Ribs, sternum and clavicle

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Benign neoplasm: Ribs, sternum and clavicle

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints